XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   73,366,766        
Beginning balance at Dec. 31, 2023 $ 52,341 $ 7 $ 0 $ 595,781 $ (23,555) $ (519,892)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (32,923)         (32,923)
Issuance of common stock to directors (in shares)   4,974        
Vesting of restricted stock units (in shares)   141,563        
Vesting of restricted stock units (2,862)     (2,862)    
Exercise of stock options (in shares)   43,460        
Exercise of stock options 345     345    
Repurchase of common stock (in shares)   (1,320,531)        
Repurchase of common stock (50,019)   (50,019)      
Stock-based compensation expense 10,606     10,606    
Other comprehensive (loss) income 12,847       12,847  
Ending balance (in shares) at Mar. 31, 2024   72,236,232        
Ending balance at Mar. 31, 2024 (9,665) $ 7 $ (50,019) 603,870 (10,708) (552,815)
Beginning balance (in shares) at Dec. 31, 2024   74,028,786        
Beginning balance at Dec. 31, 2024 (32,640) $ 7   591,281 (11,774) (612,154)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (1,177)         (1,177)
Issuance of common stock to directors (in shares)   4,735        
Vesting of restricted stock units (in shares)   167,726        
Vesting of restricted stock units (3,199)     (3,199)    
Exercise of stock options (in shares)   18,953        
Exercise of stock options 190     190    
Stock-based compensation expense 8,814     8,814    
Other comprehensive (loss) income (3,733)       (3,733)  
Ending balance (in shares) at Mar. 31, 2025   74,220,200        
Ending balance at Mar. 31, 2025 $ (31,745) $ 7   $ 597,086 $ (15,507) $ (613,331)